Veracyte backs FY24 revenue view of $394M-$402M, consensus $393.3M
The Fly

Veracyte backs FY24 revenue view of $394M-$402M, consensus $393.3M

16:29 EST Veracyte backs FY24 revenue view of $394M-$402M, consensus $393.3M

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on VCYT:

Related Articles
TheFlyVeracyte announces new data from Phase 3 STAMPEDE clinical trial
TheFlyCareDx hiring of industry vet Kennedy a positive, says BTIG
TipRanks Auto-Generated NewsdeskVeracyte Announces Expansion of Board with New Appointees
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App